FDA Guidances: Agency Fine Tunes Language, May Undertake Broad Review
This article was originally published in The Tan Sheet
Executive Summary
FDA is considering undertaking a broad guidance cleanup effort, agency Chief Counsel Daniel Troy indicated May 16 during a Generic Pharmaceutical Association legal symposium in Washington, D.C